New Position Paper from IOF-ECTS Working Group
ECTS Newsletter January 2017
Access here the January 2017 Newsletter.
2017 Membership Renewal Now Open
Renew your membership to continue accessing networking and educational opportunities, discounted registration rate to ECTS Congress and receiving other members’ only benefits.
To renew your ECTS membership, please log into the secure member’s area and using your unique username and password.
New members can join ECTS via the online application form.
If you have any queries, please do not hesitate to contact ects@hg3.co.uk.
Submit your Clinical Research to ECTS 2017 in Salzburg
Access here the full ECTS Congress Newsletter
The ECTS Annual Congress has a first class reputation for top quality in musculoskeletal research. Congress participants select this meeting for the following reasons:
- Chance to interact with colleagues and speakers
- Great topics
- Excellent place to present & discuss my research
- Quality of speakers
Salzburg May 13-16, 2017, is truly outstanding.
Therefore, ECTS 2017 is the place to present your research.
Submit your abstract by January 16, 2017
BOND approved by the European Reference Networks Board of Member States
On 15th December the Board of Member States of European Reference Networks (ERNs) voted to approve 23 ERN proposals submitted under the first wave.
BOND, the European Reference Network on Rare Bone Diseases is one of them. BOND combines skeletal dysplesias and metabolic bone diseases and its application has been coordinated by the ISDS, ESPE, ICCBH, ESE and ECTS.
European Reference Networks (ERNs) create a clear governance structure for knowledge sharing and care coordination across the EU. They are networks of centres of expertise, healthcare providers and laboratories that are organised across borders. A centre of expertise could be a clinical team, a medical centre or a hospital and must be formally accredited by its Member State.
Due to the low prevalence and complexity of rare diseases, as well as to the nature of small and scattered patient populations, the system of ERN that is being established can bring real added value to rare disease patients. By ensuring doctors have the most recent and expert knowledge possible, they will be better informed to make decisions on how to adapt treatment and care pathways. This in turn contributes to improvements in clinical outcomes and the quality of life of people living with a rare disease.
The full list of approved ERN applications is available via the official European Commission webpage. Background on European Reference Networks can also be found on the Eurordis website.
You can read more about BOND in a presentation from Dr Luca Sangiorgi, ERN Coordinator.
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- 31
- Next Page »